Novo Nordisk partners with Anthropic to accelerate AI drug discovery
Novo Nordisk and Anthropic formed a collaboration to use Claude Science and frontier models to apply AI to R&D workflows and AI-driven software development, aiming to accelerate discovery of new medicines.
Novo Nordisk and Anthropic have entered into a collaboration to apply Claude Science and frontier models to R&D workflows and AI-driven software development, with the aim of speeding the discovery of new medicines.